The Global regulatory snapshot

The European Union. The EU is pursuing a broad, class based restriction of PFAS under REACH, aiming to phase out most uses with narrowly defined derogations. Opinions and impact assessments are advancing, and industry should plan for an expansive scope that could capture thousands of fluorinated substances used as cosmetic ingredients or processing aids. Even before final adoption, retailers and several member states are signaling “PFAS free” expectations, effectively moving the market.

United States. With no federal cosmetic‑specific ban in force yet, states are driving policy. California’s PFAS‑Free Beauty Act, effective 2025, has prohibited intentionally added PFAS in cosmetics; other states (e.g., Maryland, Colorado, Washington, Minnesota and more) have enacted bans or reporting duties with staggered effective dates. This patchwork creates real compliance complexity: definitions of “PFAS” and “intentionally added,” allowable trace levels, and enforcement timelines vary by jurisdiction.

Canada. Canada is building a national picture through data collection and risk assessments while preparing risk‑management options. Existing prohibitions on certain legacy PFAS already apply; broader measures for consumer products, including cosmetics, are in development. Expect reporting thresholds, category prioritization and progressive restriction proposals.

Everywhere else. A growing number of jurisdictions beyond the EU and North America are announcing PFAS phase-outs in consumer products. Multinational brands should anticipate that restrictions will spread globally and prepare solutions that work across markets, rather than relying on market-by-market exceptions.

Three practical challenges – and pragmatic solutions

1) How to know if your product contains PFAS

The challenge. PFAS is not one chemical but a vast family. Definitions differ (class‑based vs enumerated lists), and PFAS may hide behind INCI names that don’t obviously say “perfluoro–.” Common examples in cosmetics include PTFE, perfluorinated alkyl ethers, and fluorinated silicones. Impurities, polymer backbones, and processing aids complicate the picture.

What to do?

• Demand granular ingredient disclosure from suppliers (full composition, residuals, and impurities). Require PFAS attestations aligned to the broadest reasonable definition you face.
• Centralize your data. Use reliable compliance management software that captures exact compositions of all raw materials, links them to finished goods, and enables end‑to‑end substances traceability across the portfolio. This allows rapid portfolio‑wide screening when definitions or bans&restriction lists evolve.
• Map PFAS database. Maintain a living internal library mapping INCI names, CAS numbers, synonyms, and supplier trade names to your PFAS definition(s) in your digital compliance management system. Don’t rely on prefix (e.g. perfluoro- or fluoro-) searches alone.
• Test with purpose. Where risk warrants, complement declarations with targeted analytical testing; interpret results against jurisdictional rules (e.g., “intentionally added” vs trace).

2) How to know which specific substances (INCI names) are banned

The challenge. Authorities vary between class‑based restrictions (vague) and finite lists (specific); thresholds and exemptions differ; updates are frequent. Without clarity, compliance teams can miss fluorinated ingredients that fall under broader definitions.

What to do?

• Anchor to authoritative sources, but don’t wait for perfection. Advocate for clear, exhaustive lists from regulators, but meanwhile curate an internal “single source of truth” that translates legal texts into ingredient‑level rules (INCI/CAS).
• Automate watchlists. Use pre-configured software with continuously updated ingredients classification data (e.g. PRIMS) so that new restrictions automatically flag affected formulas, raw materials and SKUs.
• Harmonize naming. Normalize supplier nomenclature to INCI/CAS in your master data so one substance under multiple trade names does not slip through.
• Close the loop with suppliers. Require timely change notifications and updated attestations when they reformulate or switch manufacturing routes.

3) How to interpret differing regional requirements for a global product

The challenge. The EU’s class‑based approach, U.S. state patchwork, and Canada’s evolving policies create mismatched scopes, definitions (“PFAS,” “intentionally added”), and thresholds. A single global formula can be compliant in one market and non‑compliant in another.

What to do?

• Design to the strictest common denominator. Remove intentionally added PFAS globally where technically feasible; build exception cases only with strong justification and clear exit plans.
• Maintain a living regulatory matrix. Track applicability by product category and jurisdiction (scope, definition, threshold, effective date, sell‑through, documentation). Make it accessible to R&D, RA, QA, marketing, and procurement.
• Institutionalize governance. Define decision rights (RACI), document interpretations, and embed PFAS checkpoints in change control, artwork review, and claims clearance (“PFAS‑free” claims carry legal risk if definitions differ).
• Scenario‑plan for EU adoption. Map which formulas, raw materials, and suppliers would be affected by broad class‑based restrictions; line up alternatives now to avoid last‑minute reformulation.

A forward‑looking Playbook

1. Commit to substitution. Prioritize high‑exposure categories (eye products, long‑wear/waterproof, SPF) and switch to non‑PFAS technologies that meet performance specs. Validate durability and sensory with robust, standardized methods.
2. Invest in data and digitalization. Accurate, structured ingredient data is your risk radar. Compliance Platforms enable rapid impact assessments, traceability and audit‑ready evidence.
3. Engage externally. Work through trade associations to push for consistent definitions, practical thresholds, and realistic timelines. Share science on alternatives and performance so policy is grounded in feasibility.
4. Be transparent. Align technical documentation, supplier attestations, and consumer‑facing claims; avoid over‑promising where trace contaminations cannot yet be ruled out analytically.

Conclusion: clarity over speed

From the compliance operator’s seat, the message is straightforward: rushed, ambiguous regulations will not solve the global PFAS problem – clarity and coordination will. When definitions, thresholds and timelines are inconsistent, companies spend resources deciphering and re‑formulating to slightly different targets instead of eliminating PFAS efficiently and sustainably. A science‑based, globally coherent framework, clear ingredient classifications, transparent scope, and synchronized timelines will accelerate real risk reduction, support innovation in alternatives and deliver credible “PFAS‑free” outcomes across markets. Until that alignment arrives, the most resilient strategy is to digitize your ingredient intelligence, design to the strictest plausible standard, and keep your suppliers – and your data – close.